Regional analysis of COPD exacerbation rates in the DYNAGITO trial

被引：0
|
作者：
Rabe, Klaus F. [1 ]
Wedzicha, Jadwiga [2 ]
Calverley, Peter M. A. [3 ]
De La Hoz, Alberto [4 ]
Voss, Florian [5 ]
Anzueto, Antonio [6 ,7 ]
Jenkins, Christine [8 ]
机构：
[1] LungClin Grosshansdorf, Grosshansdorf, Germany
[2] Imperial Coll London, Natl Heart & Lung Inst, Resp Div, London, England
[3] Univ Liverpool, Clin Sci Ctr, Inst Ageing & Chron Dis, Liverpool, Merseyside, England
[4] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[5] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[6] Univ Texas Hlth Sci Ctr San Antonio, Dept Pulm Med & Crit Care, San Antonio, TX 78229 USA
[7] South Texas Vet Hlth Care Syst, San Antonio, TX USA
[8] Univ Sydney, Concord Clin Sch, George Inst Global Hlth, Sydney, NSW, Australia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
D O I：
10.1183/13993003.congress-2019.PA5232
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA5232
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Treatment of First Exacerbation Predicts Future Risk of Exacerbations in Patients with COPD in the DYNAGITO Trial
    Calverley, P. M.
    Jenkins, C.
    Wedzicha, J. A.
    de la Hoz, A.
    Voss, F.
    Rabe, K. F.
    Anzueto, A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [2] COPD EXACERBATION RATE BY BASELINE COPD ASSESSMENT TEST SCORE IN THE DYNAGITO STUDY
    Calverley, Peter
    Jenkins, Christine
    Wedzicha, Jadwiga
    de la Hoz, Alberto
    Voss, Florian
    Rabe, Klaus
    Anzueto, Antonio
    [J]. CHEST, 2019, 156 (04) : 1758A - 1759A
  • [3] Tiotropium/Olodaterol Decreases Exacerbation Rates Compared with Tiotropium in a Range of Patients with COPD: Pooled Analysis of the TONADO®/DYNAGITO® Trials
    Jadwiga A. Wedzicha
    Roland Buhl
    Dave Singh
    Claus F. Vogelmeier
    Alberto de la Hoz
    Wenqiong Xue
    Antonio Anzueto
    Peter M. A. Calverley
    [J]. Advances in Therapy, 2020, 37 : 4266 - 4279
  • [4] Seasonal Pattern of COPD Exacerbations in the DYNAGITO Trial
    Jenkins, C. R.
    Calverley, P. M. A.
    Anzueto, A.
    De la Hoz, A.
    Voss, F.
    Rabe, K. F.
    Wedzicha, J. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] Tiotropium/Olodaterol Decreases Exacerbation Rates Compared with Tiotropium in a Range of Patients with COPD: Pooled Analysis of the TONADO(R)/DYNAGITO(R) Trials
    Wedzicha, Jadwiga A.
    Buhl, Roland
    Singh, Dave
    Vogelmeier, Claus F.
    de la Hoz, Alberto
    Xue, Wenqiong
    Anzueto, Antonio
    Calverley, Peter M. A.
    [J]. ADVANCES IN THERAPY, 2020, 37 (10) : 4266 - 4279
  • [6] EOSINOPHIL COUNTS AS A PREDICTOR OF FUTURE COPD EXACERBATIONS IN THE DYNAGITO TRIAL
    Calverley, P. M. A.
    Jenkins, C.
    Wedzicha, J. A.
    de la Hoz, A.
    Voss, F.
    Rabe, K. F.
    Anzueto, A.
    [J]. THORAX, 2019, 74 : A64 - A65
  • [7] Eosinophil counts as a predictor of future COPD exacerbations in the DYNAGITO trial
    Calverley, Peter M. A.
    Jenkins, Christine
    Wedzicha, Jadwiga
    De La Hoz, Alberto
    Voss, Florian
    Rabe, Klaus
    Anzueto, Antonio
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [8] Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited
    Keene, O. N.
    Calverley, P. M. A.
    Jones, P. W.
    Vestbo, J.
    Anderson, J. A.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (01) : 17 - 24
  • [9] COPD: A comparison of national exacerbation rates
    Simon, Annika
    [J]. PNEUMOLOGIE, 2023, 77 (02): : 67 - 67
  • [10] Relationship between baseline rescue medication use and reductions in COPD exacerbation rates: a subgroup analysis of the ETHOS trial
    Hurst, John R.
    Han, MeiLan
    Celli, Bartolome R.
    Bafadhel, Mona
    Jenkins, Martin
    Dorinsky, Paul
    Patel, Mehul
    [J]. INTERNIST, 2022, 63 (SUPPL 3): : 352 - 352
12345